|
Report Date : |
11.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
MEDSOURCE OZONE
BIOMEDICALS PRIVATE LIMITED |
|
|
|
|
Formerly known as: |
OZONE BIOMEDICALS
PRIVATE LIMITED |
|
|
|
|
Registered Office : |
238
LGF, Sant Nagar, East of Kailash, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2008 |
|
|
|
|
Date of Incorporation : |
07.05.2003 |
|
|
|
|
Com. Reg. No.: |
55-120213 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24239DL2003PTC120213 |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
Importer and
Buyer of Medical Equipments. |
RATING & COMMENTS
|
MIRA’s Rating : |
B (26) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
||
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
|
|
|
|
|
|
Maximum Credit Limit : |
USD 69000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established comp any having moderate track. There appears
to be some accumulated losses recorded by the company. However trader
relations are reported as fair. Business is active. Payments are reported to
be slow. Company can be considered for business dealings with some caution. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
India is developing into an open-market economy, yet traces
of its past autarkic policies remain. Economic liberalization, including
industrial deregulation, privatization of state-owned enterprises, and reduced
controls on foreign trade and investment, began in the early 1990s and has
served to accelerate the country's growth, which has averaged more than 7% per
year since 1997. India's diverse economy encompasses traditional village
farming, modern agriculture, handicrafts, a wide range of modern industries,
and a multitude of services. Slightly more than half of the work force is in
agriculture, but services are the major source of economic growth, accounting
for more than half of India's output, with only one-third of its labor force.
India has capitalized on its large educated English-speaking population to
become a major exporter of information technology services and software
workers. In 2010, the Indian economy rebounded robustly from the global
financial crisis - in large part because of strong domestic demand - and growth
exceeded 8% year-on-year in real terms. However, India's economic growth in
2011 slowed because of persistently high inflation and interest rates and
little progress on economic reforms. High international crude prices have
exacerbated the government's fuel subsidy expenditures contributing to a higher
fiscal deficit, and a worsening current account deficit. Little economic reform
took place in 2011 largely due to corruption scandals that have slowed legislative
work. India's medium-term growth outlook is positive due to a young population
and corresponding low dependency ratio, healthy savings and investment rates,
and increasing integration into the global economy. India has many long-term
challenges that it has not yet fully addressed, including widespread poverty,
inadequate physical and social infrastructure, limited non-agricultural
employment opportunities, scarce access to quality basic and higher education,
and accommodating rural-to-urban migration.
|
Source
: CIA |
LOCATIONS
|
Registered Office : |
238
LGF, Sant Nagar, East of Kailash, |
|
Tel. No.: |
91-11-
4162 4387/ 2643 3880 |
|
Fax No.: |
91-11-
4162 4083 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Head Office : |
Escorts Corporate Centre – 15/5, Main Mathura Road, Faridabad-121003, |
|
Tel. No.: |
91-129-5049338/ 339/ 341/ 343/ 344 |
|
Fax No.: |
91-129-5049341/ 5049340 |
|
|
|
|
Corporate Office : |
Plot
No. 7, Site No. 2, |
|
Tel. No.: |
91-129-
4113606 – 10/ 4286633 |
|
Fax No.: |
91-129
4049344 |
|
E-Mail : |
|
|
|
|
|
Regional Office: |
Kolkata V-23/22, Phone: 91-33-2410 4626 H. No. 1-6-311 & 320, Sai Ranga Apartments, Flat No. 104, 1st
Floor, Kandozi Bazaar, Park Lane, Secunderabad 500 003, Andhra Pradesh Phone: 91-40 5544 9914 |
DIRECTORS
|
Name : |
Mr. |
|
Designation : |
Director |
|
Address: |
V-23/22, |
|
Date of Birth/ Age: |
28.12.1944 |
|
Date of Appointment : |
02.04.2007 |
|
|
|
|
Name : |
Mr. Malladi
Srinivas |
|
Designation : |
Director |
|
Address : |
238, LGF, Sant
Nagar, East of Kailash, |
|
Date of Birth/Age : |
28.11.1970 |
|
Date of Appointment : |
10.05.2003 |
|
|
|
|
Name : |
Mr. Prateek Kumar
Mittal |
|
Designation : |
Director |
|
Date of Birth/Age : |
15.02.1981 |
|
Date of Appointment : |
02.04.2007 |
|
|
|
|
Name : |
Dr. Shailesh
Kumar Mittal |
|
Designation : |
Director |
|
Address : |
245, Kailash
Hills, East of Kailash, |
|
Date of Birth/Age : |
17.02.1956 |
|
Date of Appointment : |
27.09.2004 |
|
|
|
|
Name : |
Mr. Nikhil Nanda |
|
Designation : |
Director |
|
Address : |
12, Jorbagh, |
|
Date of Birth/Age : |
18.03.1974 |
|
Date of Appointment : |
04.03.2004 |
|
|
|
|
Name : |
Mr. Rajeev Kumar
Dass |
|
Designation : |
Director |
|
Address : |
R-668, New
Rajinder Nagar, |
|
Date of Birth/Age : |
14.11.1955 |
|
Date of Appointment : |
04.03.2004 |
|
|
|
|
Name : |
Dr. Kapil Garg |
|
Designation : |
Director |
|
Address : |
1933, Sector –
28, |
|
Date of Birth/Age : |
27.08.1970 |
|
Date of Appointment : |
27.09.2004 |
KEY EXECUTIVES
|
Name : |
Mr. Subhash Chand Gupta |
|
Designation : |
Company Secretary |
|
Address : |
SIS 126, Sector – 3, |
|
Mobile No. : |
91-9811833270 |
|
E-Mail : |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.09.2008
|
Names of Shareholders |
|
No. of Shares |
|
Parvesh Rani |
|
9000 |
|
Suresh Rai |
|
1000 |
|
Shailash K Mittal |
|
251000 |
|
Sanjeev K Gupta |
|
9000 |
|
Prateek K Mittal |
|
20000 |
|
Monika Rai Mittal |
|
20000 |
|
Mahabir Parshad Mittal |
|
1000 |
|
Raj Kumar Gupta |
|
1000 |
|
Shweta Rai and Sureeti Rai |
|
10 |
|
Mohak Rai and Parvesh Rai |
|
10 |
|
C Anil Kumar |
|
2980 |
|
Embee Diagnostics Private Limited |
|
500000 |
|
Nikhal Nanda |
|
675000 |
|
Manan Mittal |
|
10000 |
|
Total |
|
1500000 |
Equity Share Breakup (Percentage of Total Equity)
As on 30.09.2008
|
Category |
|
Percentage |
|
Bodies corporate |
|
33.00 |
|
Directors or relatives of directors |
|
20.00 |
|
Other top fifty share holders (other than listed above) |
|
47.00 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Importer and
Buyer of Medical Equipments. |
||||||||
|
|
|
||||||||
|
Products : |
|
GENERAL INFORMATION
|
No. of Employees : |
100 |
||||||||
|
|
|
||||||||
|
Bankers : |
v Punjab National Bank LCB, A-9, v
Vijaya
Bankm 31-C, DDA, Shopping Complex, Defence Colony, New Delhi-110024, |
||||||||
|
|
|
||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Svans and
Associates Chartered
Accountant |
|
Address : |
294, Sector -28, Faridabad-121006, |
|
Tel No.: |
91-129-4041950 |
|
Mobile No.: |
91-9810294037 |
|
E mail: |
CAPITAL STRUCTURE
As on 31.03.2008
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1900000 |
Equity Shares |
Rs. 10/- each |
Rs. 19.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1500000 |
Equity Shares |
Rs. 10/- each |
Rs.15.000
millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2008 |
31.03.2007 |
31.03.2006 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
15.000 |
15.000 |
15.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
|
4] (Accumulated Losses) |
(1.093) |
(1.174) |
(3.346) |
|
|
NETWORTH |
13.907 |
13.826 |
11.654 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
22.802 |
8.180 |
13.027 |
|
|
2] Unsecured Loans |
39.571 |
29.919 |
30.980 |
|
|
TOTAL BORROWING |
62.373 |
38.099 |
44.007 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
76.280 |
51.925 |
55.661 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
23.143 |
19.614 |
14.724 |
|
|
DEFERREX TAX ASSETS |
0.488 |
0.464 |
1.341 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
29.896
|
24.768
|
16.905 |
|
|
Sundry Debtors |
116.298
|
127.281
|
84.954 |
|
|
Cash & Bank Balances |
4.518
|
4.799
|
2.382 |
|
|
Other Current Assets |
0.000
|
0.000
|
0.000 |
|
|
Loans & Advances |
25.171
|
20.336
|
10.404 |
|
Total
Current Assets |
175.883
|
177.184
|
114.645 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
121.948
|
143.104
|
73.212 |
|
|
Provisions |
1.286
|
2.236
|
1.843 |
|
Total
Current Liabilities |
123.234
|
145.340
|
75.055 |
|
|
Net Current Assets |
52.649
|
31.844
|
39.590 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.003 |
0.006 |
|
|
|
|
|
|
|
|
TOTAL |
76.280 |
51.925 |
55.661 |
|
PROFIT & LOSS ACCOUNT
|
PARTICULARS |
31.03.2008 |
31.03.2007 |
31.03.2006 |
|
|
Sales Turnover |
314.251 |
337.758 |
196.497 |
|
|
Other Income |
2.817 |
1.921 |
2.177 |
|
|
Total Income |
317.068 |
339.679 |
198.674 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
1.365 |
5.285 |
(4.174) |
|
|
Provision for Taxation |
1.284 |
3.113 |
0.018 |
|
|
Profit/(Loss) After Tax |
0.081 |
2.172 |
(4.192) |
|
|
|
|
|
|
|
|
Earnings in Foreign Currency : |
|
|
|
|
|
|
Export Earnings |
2.895 |
3.347 |
1.684 |
|
|
|
|
|
|
|
Import value: |
116.850 |
139.504 |
88.403 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Interest Cost |
5.381 |
4.067 |
5.698 |
|
|
Depreciation & Amortization |
4.553 |
3.629 |
2.530 |
|
|
Other Expenditure |
305.769 |
326.698 |
194.620 |
|
Total Expenditure |
315.703 |
334.394 |
202.848 |
|
|
|
|
|
|
|
|
Earnings Per Share (Rs.) |
0.05 |
-- |
-- |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2008 |
31.03.2007 |
31.03.2006 |
|
PAT / Total Income |
(%) |
0.03
|
0.64
|
(2.11) |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
0.43
|
1.56
|
(2.12) |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
0.69
|
2.69
|
(3.23) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.10
|
0.38
|
(0.36) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
13.35
|
13.27
|
10.22 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.43
|
1.22
|
1.53 |
LOCAL AGENCY FURTHER INFORMATION
Trade References:
v Bioland-Korea
v Humasis
v
Bankers Charges Report
as per Registry
|
Name of the company |
Medsource Ozone Biomedicals Private
Limited |
|
|
|
Presented
By |
Mr. Rajeev Kumar Dass, Director |
|
|
|
1) Date and description of instrument creating the change |
Hypothecation of goods
and book debts to secure cash credit facility. Hypothecation of
moveable assets forming part of fixed assets, both dated 29.03.2005 Copy of Sanction
Letter. Registered with
registrar of companies on 18.05.2005 |
|
|
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs. 12.500
Millions |
|
|
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Hypothecation of
all the present and future entire goods / assets, current assets, stocks of
raw materials stores and spares, finished goods consumables which belong to
them and which now or hereinafter from time to time during the continuance of
this agreement shall be brought in stored or be in or about their premises or
unit at 238, Sant Nagar, East of Kailash, New Delhi
- 110 065 or Godown / depots at various places or any other godowns / depots
or be in course or transit from one Godown to another or wherever else the
same may be. Hypothecation
of all the present and future book debts, outstanding decrees, money
receivables, claims securities, government subsidies, investments, rights and
other moveable assets. Hypothecation
by way of first charge on all the moveable assets of the company, both
present and future part of fixed / blocks assets. |
|
|
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Margin: 25 % on
stock and book debts. Interest at the
rate of BPLR i.e. presently 10.75 % p.a. with monthly rests The interest
payable by the borrower and the periodicity of rests shall be subject to
charges in the interest rate and the periodicity of rests made by the bank /
RBI from time to time. The interest
payable by the borrower and the periodicity of rests shall be subject to
changes in the rate and the periodicity of rests made by the Bank / RBI from
time to time. |
|
|
|
5) Name and Address and description of the person entitled to the charge. |
Punjab National
Bank LCB, A-9, |
|
|
|
6) Date and brief description of instrument modifying the charge |
Deed of
Hypothecation of goods and book debts to secure Cash Credit facility. Deed of Hypothecation
of moveable assets forming part of fixed assets. Both dated
24.05.2005 |
|
|
|
7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification. |
Additional Cash
Credit limit of Rs. 3.100 Millions to the existing cash credit limit of Rs.
12.500 Millions aggregating to Rs. 15.600 Millions against the security by
way of hypothecation of stocks and book debts. Hypothecation of
all present and future stocks of raw materials, work in process, finished
goods, consumables, stores and spares which belongs to them and which now or
hereinafter from time to time during the continuance of this agreement shall
be brought in stored or be in or about their premises or unit at 238, Sant Nagar, East of Kailash, New Delhi - 110 065 or
goods / assets represented by documents drawn / covered under the letter of
credit issued under the said limit Hypothecation
of present and future entire goods / assets, current assets, Raw materials,
stores and spares, finished goods, semi finished goods, bills receivables
etc. Book
debts Hypothecation
of moveable assets of the company by way of first charge, both present and
future forming part of fixed / block assets. Margin: 25 % on
stock and book debts. Interest at the
rate of BPLR i.e. presently 10.75 % p.a. with monthly rests The interest
payable by the borrower and the periodicity of rests shall be subject to
charges in the interest rate and the periodicity of rests made by the bank /
RBI from time to time. The interest
payable by the borrower and the periodicity of rests shall be subject to
changes in the rate and the periodicity of rests made by the Bank / RBI from
time to time. |
|
|
|
Date of
instrument modifying the charge |
05.11.2007 |
|
|
|
|
|
|
|
|
This form is for |
Modification of
charge |
|
Charge
identification number of the modified |
10076549 |
|
Corporate identity
number of the company |
U24239DL2003PTC120213 |
|
Name of the
company |
MEDSOURCE OZONE
BIOMEDICALS PRIVATE LIMITED |
|
Address of the
registered office or of the principal place of business in |
238 LGF,
Sant Nagar, East of Kailash, |
|
Type of charge |
Book Debts Movable Property Other |
|
Particular of
charge holder |
Vijaya Bankm 31-C, DDA, Shopping Complex, Defence Colony, New
Delhi-110024, |
|
Nature of description
of the instrument creating or modifying the charge |
|
|
Date of
instrument Creating the charge |
29.04.2009 |
|
Amount secured by
the charge |
Rs. 10.000
Millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest Charges and
commission for issuing LC shall be as per head office guidelines. Terms of
Repayment The facility is
for a period of one year subject to review on or before 12.03.2010 Margin 25% Cash Margin Extent and
Operation of the charge First Charge to
secure FLC/ILC limit of Rs. 10.000 Millions |
|
Short particulars
of the property charged |
Charge secured by
Hypothecation of: 1) Entire stock Imported Diagnostic
instruments, raw material, stock in process, finished products of reagents,
packing material etc. 2) Entire Book Debts arising out of genuine
trade transaction due from reputed companies, both present and future 3) Plant and Machinery and other fixed Assets
of the company, both present and future 4) Document of title of goods drawn under
FLC/ ILC |
|
Particulars of
the present modification |
The charge is
modified to secure ILC/ FLC limit of Rs. 10.000 Millions charges and
commission for issuing LC shall be as per head office guideline Security
shall be entire stock of the company, entire book debts and receivables,
plant and machinery and other fixed assets of the company, both present and
future and documents of title to goods. Other terms and conditions remained
same. |
|
Corporate identity number of the company |
U24239DL2003PTC120213 |
|
Name of the
company |
MEDSOURCE OZONE
BIOMEDICALS PRIVATE LIMITED |
|
Address of the registered
office or of the principal place of
business in |
238 LGF Sant
Nagareast of Kailash, new delhi-110065, |
|
This form is for |
Creation of
charge |
|
Type of charge |
|
|
Particular of
charge holder |
Vijaya Bank 31-C,DDA Shopping
Centre, New Delhi-110024, |
|
Nature of
instrument creating charge |
Hypothecation Agreement
dated 05.11.2007 Agreement for
Hypothecation of Supply Bills and Book Debts dated 05.11.2007 Agreement for
Demand Cash Credit against Hypothecation of Stocks and Book Debts dated
05.11.2007 |
|
Date of
instrument Creating the charge |
05.11.2007 |
|
Amount secured by
the charge |
Rs. 20 millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
a) a) Rate of interest: CCH-13% floating,
additional interest @ 2% in case of default b) b) Terms of repayment: The facility is
for a period of one year c) c) Margin: 25% on paid stock
and 40% on book debts d) d) Extent and operation of the charge: 100% first charge e) e) Others The charge is
created to secure CCH limit of Rs.20 millions |
|
|
|
|
Short particulars
of the property charged |
Entire Stock such
as Diagnostic instruments, stock in process, finished goods of reagents,
stock in process, packing material stored/to be stored at Plot no.7, Site
No.2, 14/3 Milestone, Delhi,Mathura Road,Faridabad-121003, Present and future
book debts and entire fixed assets of the company. |
Fixed Assets:
· Plant and Machinery
· Air Conditioner
· Packing Machine
· Cold Storage and Generator
· Music System Projector
· Fax Machine
· Refrigerator
· Telephone Instrument
AS PER WEBSITE
PARTNERS:
Human
HUMAN was founded more than 35 years ago with the objective
of developing and manufacturing high-quality diagnostic products for clinical
laboratories to be distributed worldwide at very competitive prices. HUMAN is
today one of the few global manufacturers of diagnostic products capable of
supplying a broad range of medical laboratory equipment, clinical analyzers and
test kits to more than 160 countries.
Rayto
Rayto is founded in 2001. They are professional in developing,
manufacturing, marketing and servicing of clinical laboratory instruments for
use in research, health care and laboratories. Rayto's main products include
chemistry analyzer, microplate reader, microplate washer, and coagulation
analyzer. Thousands of laboratories all over the world are using Rayto's
products. The customers are not only from medical laboratories, doctors'
offices but also from research and industry center
URIT
Medical Electronic Company Limited
URIT Medical Electronic Group Company, Limited, which owns
more than 20 years' manufacturing experience and comprehensive RandD capacity,
has become a leading manufacturer and supplier of clinical diagnostics products
in
InTec
PRODUCTS, INC.
InTec PRODUCTS, INC., solely owned by the US ITH Group, was
established in 1989. InTec PRODUCTS, INC. is a biotech company that
specializing in research and development, manufacturing and distribution of the
medical diagnostic products. Thanks to the supports from the valued customers
worldwide
Bioland
Focusing on developing and improving ingredients for
cosmetic, medical and subsidiary food products, new chemical source from nature
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 53.57 |
|
|
1 |
Rs. 84.25 |
|
Euro |
1 |
Rs. 71.79 |
INFORMATION DETAILS
|
Report Prepared
by : |
UDS |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
4 |
|
PAID-UP CAPITAL |
1~10 |
4 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
2 |
|
--LIQUIDITY |
1~10 |
3 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
-- |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
26 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.